CN114949092A - Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof - Google Patents
Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof Download PDFInfo
- Publication number
- CN114949092A CN114949092A CN202210572885.7A CN202210572885A CN114949092A CN 114949092 A CN114949092 A CN 114949092A CN 202210572885 A CN202210572885 A CN 202210572885A CN 114949092 A CN114949092 A CN 114949092A
- Authority
- CN
- China
- Prior art keywords
- mass
- parts
- ointment
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 74
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 239000011505 plaster Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 208000025747 Rheumatic disease Diseases 0.000 title claims abstract description 10
- 230000000552 rheumatic effect Effects 0.000 title claims abstract description 10
- 206010006002 Bone pain Diseases 0.000 title claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 28
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 12
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 12
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 12
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 241000255789 Bombyx mori Species 0.000 claims abstract description 10
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 10
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 9
- 241001522129 Pinellia Species 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 7
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000000155 melt Substances 0.000 claims abstract description 6
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 235000002639 sodium chloride Nutrition 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 6
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 6
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000001138 artemisia absinthium Substances 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 229910052623 talc Inorganic materials 0.000 claims description 6
- 239000000454 talc Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 244000184734 Pyrus japonica Species 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 1
- 240000002045 Guettarda speciosa Species 0.000 claims 1
- 235000001287 Guettarda speciosa Nutrition 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 230000007803 itching Effects 0.000 abstract description 7
- 150000003839 salts Chemical class 0.000 abstract description 7
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052802 copper Inorganic materials 0.000 abstract description 4
- 239000010949 copper Substances 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 244000136948 Ocimum sanctum Species 0.000 abstract 1
- 235000004072 Ocimum sanctum Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000000422 nocturnal effect Effects 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- 239000010410 layer Substances 0.000 description 22
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 206010039073 rheumatoid arthritis Diseases 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 240000001851 Artemisia dracunculus Species 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 235000012222 talc Nutrition 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000007602 hot air drying Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000272190 Falco peregrinus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 241001522232 Pinellia ternata Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001104043 Syringa Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- FWZLYKYJQSQEPN-SKLAJPBESA-N peregrine Chemical compound OC1[C@H]2[C@@H]3C4([C@@H]5C6OC(C)=O)C(OC)CC[C@@]5(C)CN(CC)[C@H]4C6[C@@]2(OC)C[C@H](OC)[C@H]1C3 FWZLYKYJQSQEPN-SKLAJPBESA-N 0.000 description 1
- FWZLYKYJQSQEPN-UHFFFAOYSA-N peregrine Natural products OC1C2C3C4(C5C6OC(C)=O)C(OC)CCC5(C)CN(CC)C4C6C2(OC)CC(OC)C1C3 FWZLYKYJQSQEPN-UHFFFAOYSA-N 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗风湿骨痛的中药药膏、贴膏及其制备方法。本发明通过将透骨草、五花七、白芷、僵蚕、生半夏、续断、夜交藤、铜骨七、狗脊、以及食盐混合,加水浸泡,重复煮沸、提取过程若干次,将所得提取液浓缩成60℃下相对密度1.0~1.2的稠状物;将艾叶绒加入到所述稠状物中,2000rpm/min下搅拌均匀,得到稠状物;将乳香、滑石粉混合,搅拌状态下,100℃~130℃加热熔化得到熔融物,加入稠状物炒制10~15min,得到膏状药膏,该药膏涂覆在无纺布上得到贴膏。本发明药膏、贴膏在不影响患者正常生活的情况下,能起到很好的治疗效果和预防效果,并且药性较为温和,不会导致皮肤过敏、红肿、瘙痒等问题。The invention discloses a traditional Chinese medicine ointment, a patch for treating rheumatic bone pain and a preparation method thereof. In the present invention, the process of mixing S. vulgaris, five-flowered seven, Angelica dahurica, silkworm, raw Pinellia, tulsi, nocturnal vine, copper bone seven, dog ridge and salt, soaking in water, repeating the boiling and extracting process for several times, Concentrating the obtained extract into a thick substance with a relative density of 1.0 to 1.2 at 60° C.; adding mugwort velvet to the thick substance, stirring evenly at 2000 rpm/min to obtain a thick substance; mixing frankincense and talcum powder, Under stirring, heat and melt at 100°C to 130°C to obtain a melt, add the thick substance and fry for 10 to 15 minutes to obtain a paste-like ointment, which is coated on a non-woven fabric to obtain a paste. The ointment and plaster of the present invention can play a good therapeutic effect and preventive effect without affecting the normal life of the patient, and the medicinal property is relatively mild, and will not cause skin allergy, redness, itching and other problems.
Description
技术领域technical field
本发明属于中药领域,尤其涉及一种治疗风湿骨痛的中药药膏、贴膏及其制备方法。The invention belongs to the field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine ointment, a patch for treating rheumatic bone pain and a preparation method thereof.
背景技术Background technique
风湿性关节炎(rheumatic arthritis)是一种常见的急性或慢性结缔组织炎症。通常所说的风湿性关节炎是风湿热的主要表现之一,临床以关节和肌肉游走性酸楚、红肿、疼痛为特征。与A组乙型溶血性链球菌感染有关,寒冷、潮湿等因素可诱发本病。下肢大关节如膝关节、踝关节最常受累。Rheumatic arthritis is a common acute or chronic inflammation of connective tissue. Commonly referred to as rheumatoid arthritis is one of the main manifestations of rheumatic fever, clinically characterized by migratory soreness, redness, and pain in joints and muscles. It is related to group A beta-hemolytic streptococcus infection, and factors such as cold and humidity can induce the disease. Large joints of the lower extremities such as knees and ankles are most commonly affected.
关节疼痛是风湿性关节炎首要的症状,全身关节都有可能发生疼痛,但是以大关节受累更为常见,如膝关节、踝关节、肩关节、腕关节等。典型的表现为对称性、游走性疼痛,并伴有红、肿、热的炎症表现。通常急性炎症症状持续2~4周消退,并且发病特征表现为,一个关节症状消退,另一个关节的症状又可出现,也有几个关节同时发病的情况。此外,风湿性关节炎受气候变化影响较大,常在天气转冷或下雨前出现关节痛。Joint pain is the primary symptom of rheumatoid arthritis. Pain may occur in joints all over the body, but it is more common to involve large joints, such as knee joints, ankle joints, shoulder joints, and wrist joints. The typical presentation is symmetrical, migratory pain accompanied by inflammatory manifestations of redness, swelling, and heat. Usually, the symptoms of acute inflammation subside for 2 to 4 weeks, and the symptoms of the disease are characterized by the subsidence of symptoms in one joint and the reappearance of symptoms in another joint. In addition, rheumatoid arthritis is greatly affected by climate change, and joint pain often occurs before the weather turns cold or it rains.
现有技术中的治疗风湿性关节炎的膏药,普遍表现为:The plaster for the treatment of rheumatoid arthritis in the prior art is generally manifested as:
(1)针对病灶部位进行贴敷治疗,刺激性较强,贴敷时间长了会出现局部红肿、痛痒甚至溃破;此外,现有贴膏存在透气性差的问题,在贴敷表面出汗后,会导致皮肤瘙痒、肿胀;(1) It is highly irritating to apply sticking treatment to the lesion site, and local redness, swelling, itching and even ulceration may occur after a long sticking time; , causing itching and swelling of the skin;
(2)从实际临床上来说,现有药物只能暂时性的起到治疗功效,声称能根治或者不再复发的治疗药物事实上是存在夸大的嫌疑,并无法解决风湿性关节炎反复发作的问题,少有药物能从治疗结合预防的角度去解决并且反复发作的问题。(2) From a practical clinical point of view, the existing drugs can only temporarily play a therapeutic effect, and the therapeutic drugs that claim to be able to cure or not recur are in fact exaggerated and cannot solve the problem of recurrent rheumatoid arthritis. The problem is that few drugs can solve the problem from the perspective of treatment combined with prevention and it recurs.
发明内容SUMMARY OF THE INVENTION
本发明的首要目的在于提供一种治疗风湿骨痛的中药药膏。The primary purpose of the present invention is to provide a traditional Chinese medicine ointment for treating rheumatic bone pain.
本发明的再一目的再一提供上述中药药膏的制备方法。Another object of the present invention is to provide a method for preparing the above-mentioned traditional Chinese medicine ointment.
本发明的另一目的再一提供上述中药药膏制备而成的贴膏。Another object of the present invention is to provide a patch prepared from the above-mentioned traditional Chinese medicine ointment.
本发明是这样实现的,一种治疗风湿骨痛的中药药膏的制备方法,该方法包括以下步骤:The present invention is achieved in this way, a preparation method of a traditional Chinese medicine ointment for the treatment of rheumatic bone pain, the method comprises the following steps:
(1)将100~120质量份透骨草、80~100质量份五花七、40~50质量份白芷、40~50质量份僵蚕、40~50质量份生半夏、20~30质量份续断、20~30质量份夜交藤、10~20质量份铜骨七、10~20质量份狗脊、以及2~4质量份食盐混合,加水浸泡,重复煮沸、提取过程若干次,将所得提取液浓缩成60℃下相对密度1.0~1.2的稠状物;(1) Mix 100-120 parts by mass of Spermone, 80-100 parts by mass of five flowers, 40-50 parts by mass of Angelica dahurica, 40-50 parts by mass of silkworm, 40-50 parts by mass of raw Pinellia sinensis, and 20-30 parts by mass of 20-30 parts by mass of C. japonica, 10-20 parts by mass of Tonggu seven, 10-20 parts by mass of dog ridge, and 2-4 parts by mass of table salt, add water to soak, repeat the process of boiling and extraction several times, Concentrating the obtained extract into a thick substance with a relative density of 1.0-1.2 at 60°C;
(2)将40~60质量份艾叶绒加入到所述稠状物中,2000rpm/min下搅拌均匀,得到稠状物;(2) adding 40~60 parts by mass of wormwood to the thick substance, stirring evenly at 2000rpm/min to obtain the thick substance;
(3)将5~6份质量乳香、20~30质量份滑石粉混合,搅拌状态下,100℃~130℃加热熔化得到熔融物,加入所述稠状物炒制10~15min,得到膏状药膏。(3) mixing 5-6 parts by mass of frankincense and 20-30 parts by mass of talc powder, under stirring, heating and melting at 100°C~130°C to obtain a melt, adding the thick substance and frying for 10~15min to obtain a paste ointment.
优选地,在步骤(1)中,将110质量份透骨草、90质量份五花七、45质量份白芷、45质量份僵蚕、45质量份生半夏、25质量份续断、25质量份夜交藤、15质量份铜骨七、15质量份狗脊、以及3质量份食盐混合。Preferably, in the step (1), 110 parts by mass of Radix peregrine, 90 parts by mass of five flowers seven, 45 parts by mass of Angelica dahurica, 45 parts by mass of silkworm, 45 parts by mass of unripe Pinellia, 25 parts by mass of interrupted, 25 parts by mass of Parts by mass of Corydalis chinensis, 15 parts by mass of Tonggu seven, 15 parts by mass of dog ridges, and 3 parts by mass of table salt were mixed.
优选地,在步骤(2)中,将50质量份艾叶绒加入到所述稠状物中。Preferably, in step (2), 50 parts by mass of mugwort velvet is added to the thick substance.
优选地,在步骤(3)中,将4质量份乳香、2.5质量份滑石粉混合。Preferably, in step (3), 4 parts by mass of frankincense and 2.5 parts by mass of talc are mixed.
优选地,在步骤(3)中,将膏状药膏3干燥、粉碎至200~300目,加入到60~100质量份乙醇中,搅拌均匀,密封保存,得到膏状药膏。Preferably, in step (3), the paste-like ointment 3 is dried and pulverized to 200-300 mesh, added to 60-100 parts by mass of ethanol, stirred evenly, sealed and stored to obtain a paste-like ointment.
本发明进一步公开了由所述制备方法得到的中药药膏。The invention further discloses the traditional Chinese medicine ointment obtained by the preparation method.
本发明进一步公开了一种治疗风湿骨痛的中药贴膏,该中药贴膏包括基材层,该基材层一侧面的中心位置涂覆有上述中药药膏,且中心位置的外缘涂覆有暂时性辅助粘贴在人体皮肤表面作用的粘胶。The invention further discloses a traditional Chinese medicine plaster for treating rheumatic bone pain. The traditional Chinese medicine plaster includes a base material layer, the center position of one side of the base material layer is coated with the above-mentioned traditional Chinese medicine ointment, and the outer edge of the center position is coated with a base material layer. Adhesive that temporarily assists sticking on the surface of human skin.
优选地,所述基材为无纺布。Preferably, the substrate is a non-woven fabric.
本发明克服现有技术的不足,提供一种治疗风湿骨痛的中药药膏、贴膏及其制备方法。在中医药领域,能起到祛湿止痛的中药非常多,但是,每一种中药具有的功效又体现在多个方面,药物的选择配伍、制备工艺对激发所需要体现的药效起着决定性的作用。本发明基于非常临床经验的基础上,从各种常用的中药材入手,经过不断的筛选、替换,以及反复的验证的基础上,选择以透骨草、五花七搭配为君药,在贴敷治疗时,能克服在非汤服情况下能起到对祛湿止痛、活血通络的功效相互激发的作用,白芷、僵蚕、生半夏主功效在于皮肤表面的清热、解毒、皮肤呼吸孔打开促进药物溶出和析出,并且在药膏的稠状物形成起到主要作用,续断、夜交藤、铜骨七、狗脊为臣药,能很好的巩固君药的疗效,艾叶绒起到纤维骨架以及通气活血的作用,乳香、滑石粉在药膏中,不仅起到促进疗效的作用,而且在药膏表层干燥后,能在药膏层中形成均匀的皲裂细纹,在药膏层的散热、吸汗、气孔通畅中起到了中药的作用。食用盐(氯化钠)的功效不仅可以消炎杀菌,也可以通气活血,并且应该是配合艾叶绒、乳香晶粒子、滑石粉后的冷却重结晶,在吸汗熔化、干燥结晶的重复过程中,在凝固后的药膏层中起到很好的溶解药物成分、形成膜层通道、吸汗外排保持皮肤干燥中起到重要作用。The present invention overcomes the deficiencies of the prior art, and provides a traditional Chinese medicine ointment, a patch for treating rheumatic bone pain and a preparation method thereof. In the field of traditional Chinese medicine, there are many traditional Chinese medicines that can dispel dampness and relieve pain. However, the efficacy of each traditional Chinese medicine is reflected in many aspects. The selection and compatibility of drugs and the preparation process play a decisive role in stimulating the desired efficacy. effect. On the basis of very clinical experience, the present invention starts with various commonly used Chinese medicinal materials, and on the basis of continuous screening, replacement, and repeated verification, selects the combination of Tougucao and Wuhuaqi as the monarch medicine. When applying for treatment, it can overcome the mutual stimulation of the effects of removing dampness, relieving pain, promoting blood circulation and dredging collaterals in the case of non-tang The opening of the hole promotes the dissolution and precipitation of the drug, and plays a major role in the formation of the thick substance of the ointment. It plays the role of fibrous skeleton and ventilation and blood circulation. Frankincense and talcum powder in the ointment not only play a role in promoting the curative effect, but also can form uniform chapped fine lines in the ointment layer after the surface layer of the ointment is dried, and dissipate heat in the ointment layer. , sweat absorption, stomata patency played the role of traditional Chinese medicine. The effect of edible salt (sodium chloride) can not only reduce inflammation and sterilization, but also can promote blood circulation, and should be combined with wormwood, frankincense crystal particles, and talc after cooling and recrystallization. The solidified ointment layer plays an important role in dissolving the drug components, forming a film layer channel, absorbing sweat and expelling the skin to keep the skin dry.
本发明的药膏可以直接涂覆在发病的关节部位起到治疗的目的,也可以在未发病前涂覆在皮肤表面起到预防发病的目的,配合热风干燥后形成柔性的贴敷膜,内侧在人体温度下能很好的粘贴在皮肤上,外侧在室温粘贴下形成没有粘性的薄膜,或者室温较高时可以贴敷滑石粉以消除粘性。The ointment of the present invention can be directly applied to the joint site of the disease for the purpose of treatment, and can also be applied to the skin surface before the disease is present for the purpose of preventing the disease. It can be well pasted on the skin at human body temperature, and a non-sticky film can be formed on the outside at room temperature, or talc powder can be applied to eliminate stickiness when the room temperature is higher.
此外,本发明的药膏也可以直接制成贴膏的形式,该中药贴膏包括无纺布材料的基材层,该基材层一侧面的中心位置涂覆有上述中药药膏,且中心位置的外缘涂覆有暂时性辅助粘贴在人体皮肤表面作用的粘胶。该中药贴膏直接贴敷在发病的关节部位起到治疗的目的,也可以在未发病前贴敷在皮肤表面起到预防发病的目的,贴敷1~3天后将基材层撕下,中药药膏在皮肤表面形成柔性的贴敷膜。In addition, the ointment of the present invention can also be directly made into the form of a plaster, the traditional Chinese medicine plaster comprises a base material layer of non-woven material, the center position of one side of the base material layer is coated with the above-mentioned traditional Chinese medicine ointment, and the center position of the traditional Chinese medicine ointment is coated. The outer edge is coated with adhesive temporarily to assist in sticking on the surface of human skin. The traditional Chinese medicine plaster is directly applied to the joint site of the disease for the purpose of treatment, and it can also be applied to the surface of the skin before the disease is present for the purpose of preventing the disease. The ointment forms a flexible patch on the skin surface.
相比于现有技术的缺点和不足,本发明具有以下有益效果:Compared with the shortcomings and deficiencies of the prior art, the present invention has the following beneficial effects:
(1)本发明药膏、贴膏能起到很好的治疗效果和预防效果;(1) ointment and plaster of the present invention can play good therapeutic effect and preventive effect;
(2)本发明药膏、贴膏药性较为温和,不通过刺激性药物来促进皮肤对药物有效成分的被动吸收,不会出现刺痛、红肿等问题;(2) ointment and plaster of the present invention are relatively mild in nature, do not promote the passive absorption of the active ingredient of the medicine by the skin through irritating drugs, and do not cause problems such as tingling, redness and swelling;
(3)本发明药膏在皮肤表面形成的膜层具有很好的透气、散热性,不会出现皮肤瘙痒等问题;并且,该膜层具有很好的耐磨性,膜层呈现柔性,能很好的贴合人体皮肤表面,不受运动时皮肤表面形态变化导致的脱落问题;(3) The film layer formed on the skin surface of the ointment of the present invention has good air permeability and heat dissipation, and will not cause problems such as skin itching; and the film layer has good wear resistance, and the film layer is flexible and can be very Good fit to the surface of human skin, free from shedding problems caused by changes in skin surface morphology during exercise;
(4)本发明药膏在体温、汗液溶化状态下能有效的促进药物有效成分的不断析出。(4) The ointment of the present invention can effectively promote the continuous precipitation of the active ingredients of the medicine under the state of body temperature and sweat melting.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.
实施例1Example 1
(1)将100质量份透骨草、80质量份五花七、40质量份白芷、40质量份僵蚕、40质量份生半夏、20质量份续断、20质量份夜交藤、10质量份铜骨七、10质量份狗脊、以及4质量份食盐混合,加水浸泡,重复煮沸、提取过程若干次,将所得提取液浓缩成60℃下相对密度1.0~1.2的稠状物;(1) 100 parts by mass of Siberia vulgaris, 80 parts by mass of five flowers seven, 40 parts by mass of Angelica dahurica, 40 parts by mass of dead silkworm, 40 parts by mass of unripe Pinellia sinensis, 20 parts by mass of succulent, 20 parts by mass of night vine, 10 parts by mass of Mass parts of copper bone seven, 10 mass parts of dog ridge, and 4 mass parts of salt are mixed, soaked in water, repeated boiling and extraction process several times, and the obtained extract is concentrated into a thick substance with a relative density of 1.0 to 1.2 at 60 ° C;
(2)将40质量份艾叶绒加入到所述稠状物中,2000rpm/min下搅拌均匀,得到稠状物;(2) adding 40 parts by mass of wormwood to the thick substance, stirring at 2000 rpm/min to obtain the thick substance;
(3)将5份乳香、2质量份滑石粉混合,搅拌状态下,130℃加热熔化得到熔融物,加入100质量份所述稠状物炒制15min,得到膏状药膏1。(3) 5 parts by mass of frankincense and 2 parts by mass of talc were mixed, heated and melted at 130° C. under stirring to obtain a melt, and 100 parts by mass of the thick substance was added and fried for 15 minutes to obtain a paste-like ointment 1.
实施例2Example 2
(1)将120质量份透骨草、100质量份五花七、50质量份白芷、50质量份僵蚕、50质量份生半夏、30质量份续断、30质量份夜交藤、20质量份铜骨七、20质量份狗脊、以及2质量份食盐混合,加水浸泡,重复煮沸、提取过程若干次,将所得提取液浓缩成60℃下相对密度1.0~1.2的稠状物;(1) 120 parts by mass of Syringa, 100 parts by mass of Five Flowers Seven, 50 parts by mass of Angelica dahurica, 50 parts by mass of Silkworm, 50 parts by mass of unripe Pinellia ternata, 30 parts by mass of Interrupted, 30 parts by mass of Nocturne vine, 20 parts by mass of Mass parts of copper bone seven, 20 mass parts of dog ridge, and 2 mass parts of salt are mixed, soaked in water, repeated boiling and extraction process several times, and the obtained extract is concentrated into a thick substance with a relative density of 1.0 to 1.2 at 60 ° C;
(2)将60质量份艾叶绒加入到所述稠状物中,2000rpm/min下搅拌均匀,得到稠状物;(2) 60 parts by mass of wormwood velvet were added to the thick substance, and stirred at 2000 rpm/min to obtain the thick substance;
(3)将6质量份乳香、3质量份滑石粉混合,搅拌状态下,100℃加热熔化得到熔融物,加入100质量份所述稠状物炒制10min,得到膏状药膏2。(3) Mix 6 parts by mass of frankincense and 3 parts by mass of talc, and under stirring, heat and melt at 100° C. to obtain a melt, add 100 parts by mass of the thick substance, and stir-fry for 10 minutes to obtain a paste-like ointment 2 .
实施例3Example 3
(1)将110质量份透骨草、90质量份五花七、45质量份白芷、45质量份僵蚕、45质量份生半夏、25质量份续断、25质量份夜交藤、15质量份铜骨七、15质量份狗脊、以及3质量份食盐混合,加水浸泡,重复煮沸、提取过程若干次,将所得提取液浓缩成60℃下相对密度1.0~1.2的稠状物;(1) 110 parts by mass of Siberia vulgaris, 90 parts by mass of five flowers seven, 45 parts by mass of Angelica dahurica, 45 parts by mass of silkworm, 45 parts by mass of unripe Pinellia sinensis, 25 parts by mass of interrupted, 25 parts of Mass parts of copper bone seven, 15 mass parts of dog ridge, and 3 mass parts of salt are mixed, soaked in water, repeated boiling and extraction process several times, and the obtained extract is concentrated into a thick substance with a relative density of 1.0 to 1.2 at 60 ° C;
(2)将50质量份艾叶绒加入到所述稠状物中,2000rpm/min下搅拌均匀,得到稠状物;(2) adding 50 parts by mass of wormwood to the thick substance, stirring at 2000 rpm/min to obtain the thick substance;
(3)将5.5份乳香、2.5质量份滑石粉混合,搅拌状态下,120℃加热熔化得到熔融物,加入100质量份所述稠状物炒制12min,得到膏状药膏3。(3) 5.5 parts by mass of frankincense and 2.5 parts by mass of talc were mixed, heated and melted at 120° C. under stirring to obtain a melt, and 100 parts by mass of the thick substance was added and fried for 12 minutes to obtain a paste-like ointment 3 .
实施例4Example 4
该实施例4与实施例3基本相同,差别之处在于在步骤(3)中,将膏状药膏3干燥、粉碎至200~300目,加入到100质量份乙醇中,搅拌均匀,密封保存,得到膏状药膏4。This Example 4 is basically the same as Example 3, the difference is that in step (3), the paste-like ointment 3 is dried and pulverized to 200-300 mesh, added to 100 parts by mass of ethanol, stirred evenly, and sealed for storage. Get the creamy ointment 4.
实施例5Example 5
该实施例5与实施例3基本相同,差别之处在于在步骤(3)中,将膏状药膏3干燥、粉碎至200~300目,加入到60质量份乙醇中,搅拌均匀,密封保存,得到膏状药膏5。This Example 5 is basically the same as Example 3, the difference is that in step (3), the paste-like ointment 3 is dried and pulverized to 200-300 mesh, added to 60 parts by mass of ethanol, stirred evenly, and sealed for storage. Get the creamy ointment 5.
实施例6Example 6
通过滚轮将上述实施例制备的药膏3涂覆到无纺布的中心位置,在该中心位置的外缘涂覆粘胶,得到中药贴膏1。Apply the ointment 3 prepared in the above embodiment to the center of the non-woven fabric by using a roller, and coat the outer edge of the center position with adhesive to obtain the traditional Chinese medicine plaster 1 .
实施例7Example 7
通过滚轮将上述实施例制备的药膏5涂覆到无纺布的中心位置,在该中心位置的外缘涂覆粘胶,得到中药贴膏2,贴塑料膜后装袋密封,阴凉处保存。The ointment 5 prepared in the above embodiment is applied to the center of the non-woven fabric by a roller, and glue is applied to the outer edge of the center position to obtain a traditional Chinese medicine plaster 2. After sticking a plastic film, it is bagged and sealed, and stored in a cool place.
对比实施例1Comparative Example 1
该对比实施例1与实施例3基本相同,差别之处在于步骤(1)中不添加五花七,最终得到膏状药膏6。This comparative example 1 is basically the same as that of Example 3, the difference is that in step (1), the five flowers seven are not added, and finally a paste-like ointment 6 is obtained.
对比实施例2Comparative Example 2
该对比实施例1与实施例3基本相同,差别之处在于步骤(1)中不添加僵蚕、生半夏,最终得到膏状药膏7。This Comparative Example 1 is basically the same as Example 3, the difference is that in step (1), no silkworm and raw Pinellia are added, and a paste-like ointment 7 is finally obtained.
对比实施例3Comparative Example 3
该对比实施例1与实施例3基本相同,差别之处在于步骤(1)中不添加续断、夜交藤、铜骨七、狗脊,最终得到膏状药膏8。This Comparative Example 1 is basically the same as Example 3, the difference is that in step (1), no tick, Nocturne, Tonggu seven, and dog ridge are not added, and finally a paste-like ointment 8 is obtained.
对比实施例4Comparative Example 4
该对比实施例1与实施例3基本相同,差别之处在于步骤(1)中不添加食盐,最终得到膏状药膏9。This Comparative Example 1 is basically the same as Example 3, the difference is that no salt is added in step (1), and a paste-like ointment 9 is finally obtained.
对比实施例5Comparative Example 5
该对比实施例1与实施例3基本相同,差别之处在于省略步骤(3),在步骤(2)中得到的稠状物认定为药膏10。This Comparative Example 1 is basically the same as Example 3, except that step (3) is omitted, and the thick substance obtained in step (2) is identified as ointment 10.
效果实施例1Effect Example 1
该效果实施例针对上述实施例中制备的药膏的相关物理性状进行测试,测试内容包括以下方面:This effect embodiment is tested for the relevant physical properties of the ointment prepared in the above-mentioned embodiment, and the test content includes the following aspects:
(1)粘附性(1) Adhesion
将药膏涂覆在人体皮肤表面,涂覆厚度在1~2mm之间,在自然干燥或者热风干燥后,通过指甲进行剥离,若能成片状剥离、干裂脱落,表明粘附性差,否则,表明粘附性好。Coat the ointment on the surface of human skin with a thickness of 1 to 2 mm. After natural drying or hot air drying, peel it off through the nails. If it peels off in flakes, cracks and falls off, it indicates poor adhesion; otherwise, it indicates stickiness. Good attachment.
(2)成膜性(2) Film-forming properties
将药膏涂覆在人体皮肤表面,涂覆厚度在1~2mm之间,在自然干燥或者热风干燥后,肉眼观察涂覆层是否形成膜层,膜层上是否存在细微裂痕。Coat the ointment on the surface of human skin with a coating thickness of 1-2mm. After natural drying or hot air drying, visually observe whether the coating layer forms a film layer and whether there are fine cracks on the film layer.
(3)柔韧性(3) flexibility
将药膏涂覆在人体膝部关节(半月板)皮肤表面,涂覆厚度在1~2mm之间,在自然干燥或者热风干燥后,人体进行蹲、立运动10min,10次/min,肉眼观察膜层是否出现脱落、开裂情况,若有,表明柔韧性较差,若无,则表明柔韧性良好。Coat the ointment on the skin surface of the knee joint (meniscus) of the human body, and the coating thickness is between 1 and 2 mm. After natural drying or hot air drying, the human body performs squatting and standing movements for 10 minutes, 10 times/min, and the film is observed with the naked eye. Whether the layer is peeled off or cracked, if so, it indicates that the flexibility is poor, if not, it indicates that the flexibility is good.
(4)耐磨度(4) Wear resistance
将药膏涂覆在人体皮肤表面,涂覆厚度在1~2mm之间,在自然干燥或者热风干燥后,在转棒上包裹无纺布,在转棒以30rpm/min转动的情况下,无纺布的自由端与膜层接触摩擦,检测30min后,膜层的磨损情况。若膜层无破损、开裂、卷起,表明耐磨度良好,反之较差。Coat the ointment on the surface of human skin with a coating thickness of 1 to 2mm. After natural drying or hot air drying, wrap the non-woven fabric on the rotor. When the rotor rotates at 30 rpm/min, the non-woven The free end of the cloth is in contact with the film layer, and the wear of the film layer is detected after 30 minutes. If the film layer is not damaged, cracked or rolled up, it indicates that the wear resistance is good, otherwise it is poor.
(5)水溶性(5) Water-soluble
取少量药膏涂覆在干燥平滑的基材表面,涂覆厚度在1~2mm之间、面积6cm×8cm左右,干燥成膜后,保持膜的表面湿润状态,将膜表面加热至36℃~37℃,30~40min后,手指指尖皮肤触碰,检测是否能将膜成顺利提起并保持10S内不掉落,若是,表明水溶性良好,否则较差。Take a small amount of ointment and apply it to the surface of the dry and smooth substrate. The coating thickness is between 1 and 2 mm and the area is about 6 cm × 8 cm. After drying to form a film, keep the surface of the film in a moist state, and heat the surface of the film to 36°C to 37°C. ℃, after 30 to 40 minutes, touch the skin with the fingertips to check whether the film can be lifted smoothly and kept from falling within 10S. If so, it indicates that the water solubility is good, otherwise it is poor.
(6)透气性(6) Breathability
将药膏涂覆在无纺布上,涂覆厚度在1~2mm之间,干燥成膜后,将无纺布包裹在抽气筒上,包裹位置密封良好、无漏气,拉动活塞使抽气针筒内保持负压状态,保持活塞位置不动5~8min,释放对活塞施加的力,检测活塞的回位情况,以检测空气从无纺布的膜层的透气性。若活塞原位不动或者位移很小,表明膜层的透气性良好,若活塞回位1/3以上,表明膜层的透气性不好。Coat the ointment on the non-woven fabric with a coating thickness of 1-2 mm. After drying to form a film, wrap the non-woven fabric on the air suction cylinder. The wrapping position is well sealed and there is no air leakage. Pull the piston to make the air suction needle. Keep the negative pressure in the cylinder, keep the position of the piston stationary for 5-8 minutes, release the force applied to the piston, and detect the return of the piston to detect the air permeability of the air from the non-woven film layer. If the piston does not move in place or the displacement is small, it indicates that the air permeability of the membrane layer is good. If the piston returns more than 1/3, it indicates that the air permeability of the membrane layer is not good.
(7)刺激性(7) irritating
以20人(成年)为一组,将药膏涂覆在人体皮肤表面,涂覆厚度在1~2mm之间,涂覆后3天内检测皮肤是否出现瘙痒、刺痛、红肿、过敏等不良情况,若不良情况统计率在5%~10%之间,表明刺激性一般,超过10%则刺激性较强,若低于5%,表明无刺激性。Take 20 people (adults) as a group, apply the ointment on the surface of human skin with a thickness of 1 to 2 mm, and check whether the skin has itching, stinging, redness, allergies and other adverse conditions within 3 days after application. If the statistical rate of adverse conditions is between 5% and 10%, it means that the irritation is general, if it exceeds 10%, it is highly irritating, and if it is less than 5%, it means that it is not irritating.
选取上述实施例中制备的药膏进行以上项目的性能检测,结果如下表1所示:Select the ointment prepared in the above-described embodiment to carry out the performance detection of the above items, and the results are as shown in Table 1 below:
表1性能检测结果Table 1 Performance test results
表1中,粘附性指标体现在于成膜后与皮肤表面的粘连程度,更多在于成膜后与皮肤表面的表皮、毛发所形成的整体结构,水溶性则体现在于药物的溶出速度上。In Table 1, the adhesion index is reflected in the degree of adhesion to the skin surface after film formation, more in the overall structure formed with the epidermis and hair on the skin surface after film formation, and the water solubility is reflected in the dissolution rate of the drug.
由上表1可以看出,本发明药膏中各组分的配伍关系对产品的物理性状都起到了非常重要的作用,不仅体现在于某种组分的功能上,更在于组分搭配之后所形成的协同功能上。药膏7存在粘附性差、柔韧性差、耐磨度差的问题,在实际应用中容易出现破损、脱落、开裂等问题,药膏8存在柔韧性差、耐磨度差的问题,药膏9存在水溶性差、不透气,而不透气是导致其刺激性产生的最大原因;药膏10则存在粘附性差、柔韧性差、耐磨度差的问题,显然,药膏8、药膏10的结果可以推断出,乳香、僵蚕、生半夏之间的配伍关系对于粘附性、柔韧性、耐磨度的重要作用。而食盐、乳香、滑石粉之间的配伍关系对于水溶性又有着显著的因果关系。As can be seen from the above table 1, the compatibility of each component in the ointment of the present invention has played a very important role in the physical properties of the product, not only in the function of a certain component, but also in the formation of the composition after the components are matched. on the collaborative function. The ointment 7 has the problems of poor adhesion, poor flexibility, and poor wear resistance, and is prone to breakage, falling off, and cracking in practical applications. The ointment 8 has the problems of poor flexibility and poor wear resistance. Airtight, airtight is the biggest cause of its irritation; ointment 10 has problems of poor adhesion, poor flexibility, and poor wear resistance. Obviously, the results of ointment 8 and ointment 10 can be inferred that frankincense, stiffness The compatibility relationship between silkworm and raw Pinellia plays an important role in adhesion, flexibility and wear resistance. The compatibility relationship between salt, frankincense and talcum powder has a significant causal relationship for water solubility.
效果实施例2Effect Example 2
一、治疗效果1. Therapeutic effect
1、使用方法1. How to use
将药膏涂覆在人体发病关节的皮肤表面,涂覆厚度在1~2mm之间,在自然干燥、热风干燥或者表面涂抹滑石粉做去粘性处理。Coat the ointment on the skin surface of the affected joint of the human body, the coating thickness is between 1 and 2mm, and dry it naturally, dry it with hot air or apply talcum powder on the surface for de-sticking treatment.
将贴膏贴敷在人体发病关节的皮肤表面1~2h后,将贴膏的无纺布撕下,无纺布上的药膏层贴敷在皮肤上。After the plaster is applied to the skin surface of the affected joint of the human body for 1-2 hours, the non-woven fabric of the plaster is torn off, and the ointment layer on the non-woven fabric is pasted on the skin.
三个月为一个疗程,每个疗程内六次用药:第1天、第3天、第7天、第15天、第30天、第45天、第60天、第90天。Three months is a course of treatment, with six doses in each course: Day 1, Day 3, Day 7, Day 15, Day 30, Day 45, Day 60, Day 90.
2、疗效评定标准2. Efficacy evaluation standard
治愈:用药至患者疼痛症状消失即为治愈;Cure: take medicine until the patient's pain symptoms disappear, that is, cure;
好转:主要症状消失,疼痛和不适感明显消失,但还会出现轻微症状;Improvement: The main symptoms disappeared, the pain and discomfort disappeared obviously, but mild symptoms still appeared;
无效:症状、特征均无明显变化。Invalid: no significant change in symptoms and characteristics.
3、治疗对象及症状统计3. Treatment object and symptom statistics
本发明共收治患者四十余名,年龄在30~70岁之间,症状主要表现在膝关节的风湿性关节炎,骨质增生、变形以及相关的并发症,包括疼痛、眩晕、胸闷等。在实际临床实验中,本发明选用药膏3、药膏4、药膏6以及中药贴膏2分别进行治疗实验,统计结果如下表2所示:The present invention treats a total of more than 40 patients, aged between 30 and 70 years old, whose symptoms are mainly manifested in rheumatoid arthritis of the knee joint, bone hyperplasia, deformation and related complications, including pain, dizziness, chest tightness and the like. In actual clinical experiment, the present invention selects ointment 3, ointment 4, ointment 6 and traditional Chinese medicine patch 2 to carry out treatment experiment respectively, and statistical result is as shown in table 2 below:
4、典型临床病例简介4. Introduction of typical clinical cases
(1)钟某美,55岁,女,患有风湿骨病近8年,脚趾结晶变型,按疗程使用药膏3,每次用药的2~3h后热感明显,用药后不影响工作、生活,涂覆膏药之处不存在红肿刺痛瘙痒的问题,能正常的沐浴,换药时涂抹酒精纸巾擦除,疗程中疼痛感逐渐减轻并最终消失,达到临床治愈的效果。(1) Zhong Moumei, 55 years old, female, suffering from rheumatic bone disease for nearly 8 years, toe crystal deformation, using ointment 3 according to the course of treatment, the heat sensation is obvious 2 to 3 hours after each medication, and the work and life are not affected after the medication , There is no problem of redness, swelling, tingling, itching and itching in the place where the plaster is applied. You can take a normal bath. When changing the dressing, apply an alcohol tissue to wipe it off. During the course of treatment, the pain is gradually relieved and finally disappeared, achieving the effect of clinical cure.
(2)陈某兴,54岁,男,家族遗传性痛风,长期饮酒引发痛风,轻微疼痛,按疗程使用药膏药膏6,三次用药后症状没有明显改善,第四次用药后改用贴膏2,两次用药疼痛感逐渐减轻并最终消失。(2) Chen Mouxing, 54 years old, male, family inherited gout, gout caused by long-term drinking, mild pain, used ointment 6 according to the course of treatment, the symptoms did not improve significantly after the third medication, after the fourth medication, the patch 2 was used , the pain gradually relieved after two doses and finally disappeared.
(3)江某平,61岁,男,风湿性关节炎,骨质增生,按疗程使用贴膏2进行治疗,疗程中疼痛感消失明显,第四次治疗后能正常劳作。(3) Jiang Mouping, 61 years old, male, with rheumatoid arthritis and bone hyperplasia, was treated with Patch 2 according to the course of treatment, the pain disappeared obviously during the course of treatment, and he could work normally after the fourth treatment.
二、防治效果2. Prevention and control effect
对药膏3、药膏4以及中药贴膏2的治疗对象进行持续病情跟踪,跟踪期间每个月或者阴雨天气变化前使用贴膏2,贴膏2贴于原发病部位或者其他关节部位或者相关穴道部位(例如命门、环跳、殷门等)病情跟踪一年,完成病情跟踪人数10人,病情跟踪统计结果表明,一年内无患者的病情出现复发、反复的情况。Continuously track the condition of the treatment objects of ointment 3, ointment 4 and traditional Chinese medicine plaster 2. During the tracking period, use plaster 2 every month or before the rainy weather changes, and plaster 2 is attached to the primary disease site or other joints or related acupoints The disease of the parts (such as Mingmen, Huantiao, Yinmen, etc.) was tracked for one year, and the number of people who completed the disease tracking was 10. The statistical results of disease tracking showed that no patient's disease recurred or repeated within a year.
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210572885.7A CN114949092A (en) | 2022-05-25 | 2022-05-25 | Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210572885.7A CN114949092A (en) | 2022-05-25 | 2022-05-25 | Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114949092A true CN114949092A (en) | 2022-08-30 |
Family
ID=82955746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210572885.7A Pending CN114949092A (en) | 2022-05-25 | 2022-05-25 | Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114949092A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038981A (en) * | 2016-07-10 | 2016-10-26 | 马佳 | Traditional Chinese medicine composition for treating yin deficiency blood heat type painful heel |
CN106822744A (en) * | 2017-02-21 | 2017-06-13 | 广西大学 | A kind of rheumatic pain killing Chinese medicinal plaster |
CN107007720A (en) * | 2017-04-17 | 2017-08-04 | 王晶 | A kind of black plaster and its preparation technology and application |
CN109481101A (en) * | 2018-12-28 | 2019-03-19 | 西安交通大学医学院第二附属医院 | A kind of anterior approach self-retaining artificial vertebral body |
-
2022
- 2022-05-25 CN CN202210572885.7A patent/CN114949092A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038981A (en) * | 2016-07-10 | 2016-10-26 | 马佳 | Traditional Chinese medicine composition for treating yin deficiency blood heat type painful heel |
CN106822744A (en) * | 2017-02-21 | 2017-06-13 | 广西大学 | A kind of rheumatic pain killing Chinese medicinal plaster |
CN107007720A (en) * | 2017-04-17 | 2017-08-04 | 王晶 | A kind of black plaster and its preparation technology and application |
CN109481101A (en) * | 2018-12-28 | 2019-03-19 | 西安交通大学医学院第二附属医院 | A kind of anterior approach self-retaining artificial vertebral body |
Non-Patent Citations (3)
Title |
---|
吴震西;等: "痹证的中医外治疗法", 中国社区医师, no. 10, 15 October 1995 (1995-10-15), pages 4 * |
徐思越;等: "自体骨软骨栓移植术治疗膝关节股骨软骨缺损12例临床观察", 陕西医学杂志, vol. 40, no. 08, 5 August 2011 (2011-08-05), pages 1056 - 1057 * |
朱静;等: "中医药防治骨质增生病概况", 江西中医学院学报, vol. 24, no. 06, 15 December 2012 (2012-12-15), pages 86 - 92 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114558110B (en) | Mussel mucin product and application thereof in inhibiting skin inflammation | |
CN103933603B (en) | Human epidermal growth bio-medical glue and preparation method thereof urged by a kind of chitosan | |
CN108186711A (en) | Promote the pharmaceutical composition of wound healing | |
CN110075248A (en) | A kind of external application application for gout swelling and pain relieving | |
CN100544751C (en) | The external Chinese patent medicine and the manufacture method of treatment ecthyma | |
CN101934015B (en) | A traditional Chinese medicine composition for treating thyroid gland and preparation method thereof | |
CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
WO2018137319A1 (en) | Application of sarcococca vagans, chinese medicinal ointment for treating skin disease, preparation method and application thereof | |
CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
CN100515447C (en) | Ointment for treating psoriasis in ordinary type, and preparation method | |
CN106963923A (en) | A kind of Chinese medicine composition and preparation method and application with analgesic activity | |
CN114949092A (en) | Traditional Chinese medicine ointment and plaster for treating rheumatic ostealgia and preparation method thereof | |
CN101019935A (en) | Chinese medicine for treating burns and scalds | |
CN103110707B (en) | Traditional Chinese medicine babu (Chinese character) paste for removing swelling and clearing away toxin | |
CN103599229B (en) | A kind of anus washing liquid and preparation method thereof | |
CN102274342B (en) | External sticking plaster | |
JP2002370973A (en) | Patch agent of crude medicine | |
CN103830437B (en) | A kind of fumigation and wash method conditioning liquid for accelerating fracture detumescence | |
CN114569663A (en) | Pharmaceutical composition and preparation method and application thereof | |
CN101721578B (en) | Traditional Chinese medicine for treating burns and scalds | |
CN111759905A (en) | Cataplasm for treating osteoarthritis and preparation method thereof | |
CN103520415A (en) | Medicament for treating traumatic injuries | |
CN1374095A (en) | Burn treating medicine and its prepn | |
CN108295218B (en) | A kind of formula of plaster for treating acute soft tissue injury | |
CN108704028A (en) | A kind of Chinese medicine composition and preparation method thereof for removing tinea, treating tinea pedis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |